Does NIRAPARIB Cause Acute myeloid leukaemia? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Acute myeloid leukaemia have been filed in association with NIRAPARIB (ZEJULA). This represents 0.5% of all adverse event reports for NIRAPARIB.
116
Reports of Acute myeloid leukaemia with NIRAPARIB
0.5%
of all NIRAPARIB reports
52
Deaths
38
Hospitalizations
How Dangerous Is Acute myeloid leukaemia From NIRAPARIB?
Of the 116 reports, 52 (44.8%) resulted in death, 38 (32.8%) required hospitalization, and 59 (50.9%) were considered life-threatening.
Is Acute myeloid leukaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Acute myeloid leukaemia?
CYCLOPHOSPHAMIDE (1,675)
VENETOCLAX (1,591)
DOXORUBICIN (1,503)
AZACITIDINE (1,156)
ETOPOSIDE (1,069)
VINCRISTINE (984)
CYTARABINE (837)
CARBOPLATIN (812)
RITUXIMAB (735)
METHOTREXATE (728)
Which NIRAPARIB Alternatives Have Lower Acute myeloid leukaemia Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP